Prostate cancer decisions — 2024

The Veteran's prostate cancer is granted on a presumptive basis due to herbicide agent exposure.,Left knee scars are granted with a compensable rating, subject to further development if needed.

The Veteran's TDIU claim was denied prior to March 14, 2019 due to insufficient evidence showing he could not secure and follow a substantially gainful occupation solely by reason of his service-connected disabilities. From March 14, 2019, the Veteran's TDIU claim was granted as his combined disability rating met the schedular criteria.

The Board has remanded the Veteran's claims for heart disability, prostate cancer, and erectile dysfunction due to inadequate medical opinions. The Veteran is being asked to provide new VA examinations to determine if his conditions are related to service exposure.

The Veteran's prostate cancer and related disabilities are being remanded for further evaluation. Service connection is also being remanded for peripheral neuropathy of the right hand, adenocarcinoma polyp in the colon, and bilateral lower extremity peripheral neuropathy.

The Veteran's prostate cancer is being remanded for further review due to potential exposure to herbicide agents during his service in Thailand.

The Veteran's claim for a higher rating and an earlier effective date for prostate cancer was denied. The Board found that the evidence did not support a rating in excess of 40 percent, and the effective date could not be set prior to February 1, 2018.

The Veteran's prostate cancer resulted in erectile dysfunction without penile deformity, and a separate noncompensable rating for this condition was granted. The Veteran also received a 100% evaluation for his prostate cancer effective August 4, 2023.

The Veteran's service-connected right ear hearing loss is found to be the proximate cause of his diagnosed adjustment disorder with anxiety and depressed mood. The Board has granted service connection for this condition.

The Veteran's service connection claims for ischemic heart disease (CAD), prostate cancer, and a psychiatric disorder secondary to prostate cancer are granted. The claim of service connection for depression is remanded due to procedural errors.

The Veteran's service connection claims for hypothyroidism, prostate cancer, and hypertension due to herbicide exposure are granted. The Board finds the Veteran exposed to herbicide agents in Korea and grants presumptive service connection for these conditions. Service connection is remanded for pituitary microadenoma, erectile dysfunction, and Alzheimer's disease.

The Veteran's prostate cancer residuals, rated as a voiding dysfunction, did not result in the need for an appliance or absorbent material changed more than four times per day from August 1, 2020. The appeal is denied.

The Veteran's prostate cancer is granted service connection due to presumed exposure to herbicide agents in Korea. The secondary service connection for erectile dysfunction as a result of the prostate cancer is also granted.

The Veteran's TDIU and DEA from January 1, 2012, to September 10, 2019 are granted due to service-connected disabilities.

The Veteran's service connection claims for ischemic heart disease (CAD) and prostate cancer are granted due to presumed exposure to herbicides. The claim for depression secondary to prostate cancer is remanded as there was a pre-decisional duty to assist error.

The Veteran's service-connected disabilities, including prostate cancer residuals and depressive disorder, render him unable to engage in substantially gainful employment as of January 1, 2018. His TDIU claim is granted.

The Veteran's diabetes mellitus type II is rated at 20 percent, and his prostate cancer from February 1, 2009 to July 22, 2012 is not compensable.

The Veteran's residuals of prostate cancer required the wearing of absorbent materials which must be changed 2 to 4 times per day from January 11, 2016 to September 20, 2021.,From September 21, 2021, his residuals of prostate cancer required the wearing of absorbent materials which must be changed more than 4 times per day.

The Veteran's PTSD is currently rated at 70 percent, which does not meet the criteria for a higher rating. The appeal regarding TDIU and DEA was dismissed as it pertained to an adjacent appeal.

The Board has remanded the case due to a failure to obtain a VA examination prior to denying the Veteran's claim for service connection of prostate cancer residuals. The examiner is required to determine if there is a nexus between the Veteran's claimed disability and his active service, including toxic exposures related to his MOS as an ammunitions specialist.

The Veteran's heart disease, prostate cancer, melanoma, and squamous cell carcinoma are granted as service connected due to in-service exposure to contaminated water at Camp Lejeune.